Background: Carotid duplex ultrasound (CDUS) is often used as a screening test in cardiac patients. Significant cardiac dysfunction may affect the accuracy of CDUS because of alterations in the cardiac cycle. Left ventricular assist devices (LVADs) are frequently implanted as a bridge to cardiac transplant. A review of CDUS in patients with LVADs was performed to assess their influence on arterial waveforms and velocities.
Methods: Patients with LVADs undergoing carotid duplex in our Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL)-accredited vascular laboratory were identified. The carotid waveforms were analyzed qualitatively and quantitatively. Common carotid artery (CCA) and internal carotid artery (ICA) peak-systolic and end-diastolic velocities (PSV and EDV) were recorded as ICA/CCA velocity ratios. In patients with prior CDUS, the changes between these values were analyzed before and after LVAD placement.
Results: Of the 14 patients with LVADs treated in our institution over the past 2 years, 4 had CDUS (8 ICAs). Mean age was 57 years, and 3 of the 4 patients were men. All patients were free of cerebrovascular symptoms. Qualitatively, there was significant blunting of the CCA and ICA waveforms noted in all 8 ICAs. The degree of stenosis was reported as ≤15% in 7 ICAs and 15-45% in 1 ICA. The mean ICA PSV was 61.8 cm/sec. Two patients (4 ICAs) had CDUS before and after LVAD placement. Comparing pre- and post-LVAD values, the mean ICA PSV decreased by 42% (54 cm/sec; P = 0.04) and EDV increased by 51% (17 cm/sec; P = 0.3). The PSV and EDV ratios were unchanged. Overall assessment of category of stenosis was unchanged in 2 ICAs (≤15%), one decreased from moderate to mild (45-70% to 15-45%), and one ICA changed from 45-70% to ≤15% based on the decreased ICA PSV.
Conclusions: The presence of an LVAD has a significant influence on CDUS findings. There is a qualitative change in the ICA with blunting of the waveform, and a quantitative change with a decreased PSV and an increased EDV. Compared with pre-LVAD placement, there is a significant decrease in PSV which may affect the accuracy of CDUS using velocity-based criteria. Further study into the accuracy of CDUS in patients with LVADs is necessary.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.avsg.2013.11.013 | DOI Listing |
Rev Cardiovasc Med
January 2025
Center for Preclinical Surgical & Interventional Research, The Texas Heart Institute, Houston, TX 77030, USA.
The evolution of left ventricular assist devices (LVADs) from large, pulsatile systems to compact, continuous-flow pumps has significantly improved implantation outcomes and patient mobility. Minimally invasive surgical techniques have emerged that offer reduced morbidity and enhanced recovery for LVAD recipients. Innovations in wireless power transfer technologies aim to mitigate driveline-related complications, enhancing patient safety and quality of life.
View Article and Find Full Text PDFLife (Basel)
January 2025
Internal Medicine Department, College of Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Background: Heart failure (HF) is a chronic condition that significantly affects morbidity and mortality. For patients with end-stage HF who are not candidates for heart transplantation, left ventricular assist devices (LVADs) provide mechanical circulatory support as a long-term solution, known as destination therapy (DT).
Objective: This meta-analysis aims to synthesize evidence on the survival rates, complications, and quality-of-life improvements associated with LVADs used as destination therapy in patients with end-stage HF.
J Neurointerv Surg
January 2025
Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Background: Left ventricular assist devices (LVADs) are used as definitive therapy or as a bridge to heart transplant in patients with advanced heart failure. Thromboembolic complications such as acute ischemic stroke (AIS) are common among patients with LVAD support. This study aims to evaluate the current evidence on the efficacy and safety of mechanical thrombectomy (MT) in patients with AIS due to large vessel occlusions (LVO) and LVAD-support.
View Article and Find Full Text PDFArtif Organs
January 2025
Division of Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons and NewYork-Presbyterian Hospital, New York, New York, USA.
Background: GLP-1 RAs improve cardiometabolic outcomes in obese, diabetic, and heart failure patients. Data on the safety and efficacy of GLP-1 RA in advanced heart failure with durable LVAD is limited.
Objectives: To assess the safety and efficacy of GLP-1 RA in durable LVAD patients.
Indian J Thorac Cardiovasc Surg
February 2025
Department of Engineering Design, Indian Institute of Technology Madras, Chennai, India.
Purpose: Despite significant improvements in the design and performance of continuous flow left ventricular assist devices (CFLVADs), one of the most important reasons hampering further penetration of this technology is the occurrence of adverse events, especially strokes. One of the well-known risk factors for strokes is hypertension which is particularly common in patients undergoing a CFLVAD implant. While the device is implanted in the heart, strokes happen due to pathology in the brain and we hypothesised that modelling the blood flow in the circle of Willis might shed light on the causation of strokes in this situation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!